Logo Image
Opinion|Videos|July 9, 2024

Examining Challenges with Drug Switching and Step Therapy in MS Treatment

Key opinion leaders discuss the challenges associated with step therapy requirements after initially selecting a drug class, the patient factors considered when deciding to switch a patient with non-relapsing secondary progressive multiple sclerosis to a different therapy, and whether payers commonly employ step therapy between different drug classes.

Episodes in this series

Video content above is prompted by the following questions:

  • Do you ever encounter challenges with step therapy requirements after initially selecting a drug class?
  • What patient factors do you consider when deciding to switch a patient to a different therapy in patients diagnosed with non-relapsing secondary progressive multiple sclerosis?
  • Are step therapies typically used for drugs within the same class, or do payers typically use step therapy between different classes of drugs?

Related Content